XSHG603939
Market cap3.86bUSD
Jan 17, Last price
23.38CNY
1D
0.78%
1Q
3.54%
Jan 2017
-21.12%
IPO
51.62%
Name
Yifeng Pharmacy Chain Co Ltd
Chart & Performance
Profile
Yifeng Pharmacy Chain Co., Ltd. retails pharmaceutical products in China. As of March 31, 2021, it operates approximately 6,279 pharmaceutical chain stores in Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The company was founded in 2001 and is based in Changsha, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 22,588,227 13.59% | 19,886,396 29.75% | |||||||
Cost of revenue | 19,699,824 | 17,061,873 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 2,888,404 | 2,824,523 | |||||||
NOPBT Margin | 12.79% | 14.20% | |||||||
Operating Taxes | 456,663 | 450,292 | |||||||
Tax Rate | 15.81% | 15.94% | |||||||
NOPAT | 2,431,741 | 2,374,231 | |||||||
Net income | 1,411,985 11.90% | 1,261,841 42.12% | |||||||
Dividends | (288,682) | (215,583) | |||||||
Dividend yield | 0.60% | 0.47% | |||||||
Proceeds from repurchase of equity | (3,521) | (1) | |||||||
BB yield | 0.01% | 0.00% | |||||||
Debt | |||||||||
Debt current | 103,484 | 1,277,800 | |||||||
Long-term debt | 4,544,638 | 4,130,821 | |||||||
Deferred revenue | 54,094 | 54,690 | |||||||
Other long-term liabilities | 4 | 1 | |||||||
Net debt | (1,141,473) | 962,013 | |||||||
Cash flow | |||||||||
Cash from operating activities | 4,663,259 | 3,920,267 | |||||||
CAPEX | (739,925) | ||||||||
Cash from investing activities | (3,011,635) | ||||||||
Cash from financing activities | (2,101,244) | ||||||||
FCF | 1,658,668 | 1,986,636 | |||||||
Balance | |||||||||
Cash | 5,196,627 | 4,162,564 | |||||||
Long term investments | 592,969 | 284,044 | |||||||
Excess cash | 4,660,184 | 3,452,288 | |||||||
Stockholders' equity | 6,427,479 | 5,130,112 | |||||||
Invested Capital | 8,283,610 | 8,897,985 | |||||||
ROIC | 28.31% | 26.95% | |||||||
ROCE | 22.27% | 22.83% | |||||||
EV | |||||||||
Common stock shares outstanding | 1,209,999 | 1,006,735 | |||||||
Price | 40.04 -12.19% | 45.60 -17.26% | |||||||
Market cap | 48,448,369 5.54% | 45,907,102 -16.90% | |||||||
EV | 47,949,551 | 47,434,503 | |||||||
EBITDA | 4,720,194 | 4,265,624 | |||||||
EV/EBITDA | 10.16 | 11.12 | |||||||
Interest | 160,529 | 165,209 | |||||||
Interest/NOPBT | 5.56% | 5.85% |